Randomized placebo‐controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis

Abstract

Based on this randomized controlled trial, autologous bone marrow MSC transplantation through peripheral vein probably has no beneficial effect in cirrhotic patients. Further studies with higher number of patients are warranted to better clarify the impact of MSC infusion through peripheral vein or portal vein in cirrhosis.